. 05/2010, New Paper
A paper titled "Histone modifications and chromatin organization in prostate cancer" has been accepted by Epigenomics.
A paper titled "New syntax to describe local continuous structure-sequence information for recognizing new pre-miRNAs" has been accepted by Journal of Theoretical Biology .
A Texas CPRIT grant was funded. We will use ChIP-seq and RNA-seq to analyze Androgen Receptor (AR) function in Prostate Cancer with Dr. Weigel at BCM.
A planning award for the Lonestar Oncology Network for EpigeneticS Therapy And Research (LONESTAR) was funded. This project will bring together a "dream team" in epigenetics research from UT Southwestern, Baylor College of Medicine, and M.D. Anderson. We will direct the bioinformatics component for LONESTAR.
Deqiang Sun will join us as a postdoc fellow. Deqiang has a PhD in Condensed Matter Physics from Texas A&M University. Welcome!
Wei Li is an invited speaker in the American Association for Cancer Research (AACR) Special Conference on Cancer Epigenetics at Puerto Rico.
Dr.Bert O'Malley's paper, Global Characterization of Transcriptional Impact of the SRC-3 Coregulator, has been accepted by Molecular Endocrinology. Liguo and Wei are co-authors on the paper.
Liguo's paper titled 'A Statistical Method for the Detection of Alternative Splicing Using RNA-seq' has been accepted by PLoS ONE. Congratulations Liguo!
Wei Li received a New Investigator Award from the Department of Defense (DOD) Prostate Cancer Research Program (PCRP). Cheers!
Wei Li gave a Keynote Presentation at the Symposium on Advances in Cell Signaling, Cancer Prevention and Therapy at South Padre Island, Texas.
A prestigious NIH Challenge grant was funded. We will use ChIP-seq to analyze RXRa binding in mouse liver with Dr. Karpen at Texas Children's Hospital.
A two-year $2.5 million NIH Grand Opportunity (GO) grant was funded. We will study aging epigenomics with Drs. Darlington and Goodell at BCM.
A prestigious NIH Challenge grant was funded. We will use RNA-seq to characterize patient cardiac progenitors with Dr. Pu at Harvard Medical School.
Yuanxin's paper titled 'BSMAP: whole genome Bisulfite Sequence MAPping program' has been accepted by BMC Bioinformatics. Congratulations Yuanxin!
A paper titled 'Reprogrammed Androgen Receptor Function in Androgen-Independent Prostate Cancer' has finally been accepted by Cell.